Skip to Main Content

Paper Details

ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.
Cancer Res
9
2023
Akt, ClpP, DIPG, DIPGs, DMG, DRD2, Diffuse midline gliomas, H3K27, ONC201, PI3K, PIK3CA, PIK3CA-mutations, TP53, TP53-mutations, childhood cancers, diffuse intrinsic pontine gliomas, diffuse midline glioma, mitochondrial protease ClpP, patient, paxalisib, tricarboxylic acid
Author NameAffiliation
Ryan J DuchatelThe University of Newcastle
Sridevi YadavilliChildren's National Hospital
Wai Chin ChongHudson Institute of Medical Research
Bryan W Day
Ron Firestein
Nicholas G GottardoTelethon Kids Institute
Sebastian M WaszakUniversity of Oslo
Sebastian M WaszakUniversity of Oslo
Martin R LarsenUniversity of Southern Denmark
Nicholas A VitanzaSeattle Children's Research Institute
Javad NazarianChildren's National Medical Center
Javad NazarianChildren's National Medical Center
Carl KoschmannUniversity of Michigan-Ann Arbor
Carl KoschmannUniversity of Michigan-Ann Arbor
Sabine MuellerUniversity of California san francisco
Sabine MuellerUniversity of California san francisco
Jason E CainHudson Institute of Medical Research
Matthew D DunThe University of Newcastle
  • 1 - 18

Datasets

Release 1.2